• Unveiling Apoptosis Dynamics: TUNEL Kit Insights for SCI Mod

  2026-04-28

  Explore how the TUNEL Apoptosis Detection Kit enables precise DNA fragmentation detection in spinal cord injury research. This article uniquely bridges molecular assay design with translational insight, equipping apoptosis researchers with practical, evidence-based guidance.

• Diclofenac: Applied Workflows in COX Inhibition & Organoid R

  2026-04-28

  Diclofenac, a high-purity non-selective COX inhibitor from APExBIO, is empowering advanced inflammation and pain signaling studies, particularly in organoid-based pharmacokinetic assays. This article details practical workflows, troubleshooting strategies, and protocol enhancements that maximize data reliability and translational relevance when using Diclofenac in cutting-edge cellular models.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow

  2026-04-27

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat IgG in fluorescence-based immunoassays. This reagent is best suited for workflows such as immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA where reliable signal amplification is required. It should not be used for detection of non-goat primary antibodies or applications outside validated immunodetection settings.

• Integrating Fractional and Relative Viability for Drug Respo

  2026-04-27

  Schwartz's dissertation advances cancer drug evaluation by rigorously distinguishing between proliferation inhibition and cell death using refined in vitro viability metrics. The findings clarify how most anti-cancer drugs exert both cytostatic and cytotoxic effects with distinct kinetics, informing more precise experimental design and interpretation in cancer research.

• Practical Guide: Cy5 NHS ester(Et) for Fluorescent Labeling

  2026-04-26

  Cy5 NHS ester(Et) enables water-soluble, amine-reactive fluorescent labeling of proteins and peptides for applications such as immunofluorescence staining and flow cytometry. It is not suitable for protocols requiring ethanol solubility or long-term solution storage. This guide outlines actionable setup, protocol, and troubleshooting steps for optimal use.

• ROS-Responsive Nanoparticles Induce Cuproptosis for Cancer I

  2026-04-25

  This study introduces a novel ROS-sensitive nanoparticle (NP@ESCu) that co-delivers elesclomol and copper to induce cuproptosis in bladder cancer cells. The approach enhances both direct tumor cell killing and immunotherapeutic efficacy, especially when combined with αPD-L1, offering a promising strategy for overcoming resistance in cancer immunotherapy.

• Brassinolide: Dissecting Structure–Activity for Assay Precis

  2026-04-24

  Explore the advanced structure–activity insights of Brassinolide, a leading plant sterol and research tool. This article reveals how in-depth biosynthetic and bioassay data can optimize both plant and biomedical experiments, distinguishing APExBIO Brassinolide from existing workflows.

• IGF2BP3–FZD1/7 Axis Drives Carboplatin Resistance in TNBC

  2026-04-24

  This study delineates a novel mechanism by which IGF2BP3, a dominant m6A reader, enhances stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC) by stabilizing FZD1/7 transcripts and activating β-catenin signaling. Targeting the IGF2BP3–FZD1/7 axis is shown to disrupt cancer stem cell maintenance and improve chemotherapeutic efficacy, offering a promising pathway for intervention in TNBC.

• Optimizing Assays with EZ Cap™ Firefly Luciferase mRNA (5-mo

  2026-04-23

  This article addresses common laboratory challenges in cell viability and translation efficiency assays, illustrating how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) (SKU R1013) provides robust, reproducible, and immune-evasive bioluminescent readouts. Researchers will learn how the Cap 1 structure, 5-moUTP modification, and poly(A) tail stability converge to deliver superior sensitivity and workflow reliability.

• Eltanexor (KPT-8602): Redefining Nuclear Export Inhibition i

  2026-04-23

  Explore how Eltanexor (KPT-8602) advances cancer therapeutics by targeting nuclear export pathways. This article offers a deep scientific analysis and practical assay insights for researchers, setting it apart from prior content.

• Acetoacetic Acid Sodium Salt in Energy Metabolism Research

  2026-04-22

  Acetoacetic acid sodium salt (sodium 3-oxobutanoate) is redefining metabolic research with superior solubility, purity, and translational relevance. This guide delivers actionable workflows, troubleshooting strategies, and protocol insights to maximize reproducibility and impact in diabetes and fatty acid catabolism studies.

• Vitamin C (CAS 50-81-7): Bridging Anticancer and Antiviral F

  2026-04-22

  This thought-leadership article explores how high-purity Vitamin C (CAS 50-81-7) is redefining the landscape at the intersection of cancer and antiviral research. Leveraging recent organoid innovations, including iPSC-derived HEV infection models, we dissect mechanistic insights and strategic imperatives for translational scientists. The article uniquely blends robust experimental validation, actionable protocols, and visionary guidance, positioning APExBIO’s Vitamin C as an enabling tool for next-generation preclinical innovation.

• Tamsulosin (R)-5-(2-ethoxyphenoxy)ethyl: Applied Urological

  2026-04-21

  Harness Tamsulosin's receptor selectivity and high solubility to streamline smooth muscle and GPCR pathway studies. This guide details data-backed protocols, troubleshooting, and advanced workflow optimizations for urological research, referencing the latest meta-analytic evidence.

• NU6300’s Selective Inhibition of Gasdermin D: Mechanistic Ad

  2026-04-21

  Jiang et al. identify NU6300 as a covalent inhibitor targeting cysteine-191 of gasdermin D (GSDMD), thereby blocking its cleavage and palmitoylation. This work illuminates a new mechanism for regulating pyroptosis and highlights GSDMD as a promising therapeutic target for inflammatory diseases.

• Demethyleneberberine: Applied Workflows in Neurodegeneration

  2026-04-20

  Demethyleneberberine (DMB) is redefining neuroinflammation and cancer research with its multi-pathway inhibition and high reproducibility. This guide translates bench evidence into robust workflows, troubleshooting insights, and next-stage applications for DMB in translational disease modeling.

450 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page